Qureight
End-to-end imaging company for clinical trials with a focus on lung and heart disease.
$20MSeries B
Role not disclosedLoading investors…
Loading investors…
Activity from announced rounds
End-to-end imaging company for clinical trials with a focus on lung and heart disease.
Building the sovereign infrastructure layer for high-consequence operations and AI-driven systems
Develops quantum compression technology to enable computation on existing quantum and classical systems
Pitching XTX Ventures? Send the deck from a free RoundOS data room and see which pages they read.
Create a free room